BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 118 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $772,000 | +13.9% | 12,387 | +10.8% | 0.00% | 0.0% |
| Q4 2018 | $678,000 | -42.1% | 11,180 | -44.1% | 0.00% | 0.0% |
| Q3 2018 | $1,170,000 | +158.3% | 19,996 | +98.0% | 0.00% | 0.0% |
| Q2 2018 | $453,000 | +1.1% | 10,098 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $448,000 | +2.3% | 10,098 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $438,000 | -6.8% | 10,098 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $470,000 | -6.0% | 10,098 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $500,000 | +3.7% | 10,098 | +14.8% | 0.00% | 0.0% |
| Q1 2017 | $482,000 | +9.8% | 8,793 | +11.5% | 0.00% | 0.0% |
| Q4 2016 | $439,000 | +21.9% | 7,886 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $360,000 | +14.3% | 7,886 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $315,000 | +29.1% | 7,886 | +12.5% | 0.00% | – |
| Q1 2016 | $244,000 | -18.9% | 7,009 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $301,000 | -1.3% | 7,009 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $305,000 | -15.7% | 7,009 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $362,000 | +82.8% | 7,009 | +38.8% | 0.00% | – |
| Q1 2015 | $198,000 | +1.5% | 5,049 | 0.0% | 0.00% | – |
| Q4 2014 | $195,000 | +9.6% | 5,049 | 0.0% | 0.00% | – |
| Q3 2014 | $178,000 | +30.9% | 5,049 | 0.0% | 0.00% | – |
| Q2 2014 | $136,000 | – | 5,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS INC | 2,300 | $203,550,000 | 0.00% |